Gene Therapy for Blinding Pediatric Eye Disorders.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advances in Pediatrics

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yapd.2015.04.012PMID 26205114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promising and delivering gene therapies for vision loss.

  2015cited by this paper
• Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.

  2014cited by this paper
• BBS mutations modify phenotypic expression of CEP290-related ciliopathies.

  2014cited by this paper
• Cone specific promoter for use in gene therapy of retinal degenerative diseases.

  2014cited by this paper
• Genersatztherapie bei genetisch bedingter Zapfenblindheit

  2014cited by this paper
• Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.

  2014cited by this paper
• [Gene replacement therapy in achromatopsia type 2].

  2014cited by this paper
• The Argus II Retinal Prosthesis: 12-month outcomes from a single-study center.

  2014cited by this paper
• RNA Interference-Based Therapy for Spinocerebellar Ataxia Type 7 Retinal Degeneration

  2014cited by this paper
• EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat

  2014cited by this paper
• Induction of pluripotency by defined factors

  2014cited by this paper
• Retinal structure and function in achromatopsia: implications for gene therapy.

  2014cited by this paper
• Seeing the Light

  2013cited by this paper
• Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa

  2013cited by this paper
• Genome engineering using the CRISPR-Cas9 system

  2013cited by this paper
• Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1.

  2013cited by this paper
• Ectopic Expression of Human BBS4 Can Rescue Bardet-Biedl Syndrome Phenotypes in Bbs4 Null Mice

  2013cited by this paper
• A comprehensive review of retinal gene therapy.

  2013cited by this paper
• Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.

  2013cited by this paper
• Advances in gene therapy technologies to treat retinitis pigmentosa

  2013cited by this paper
• Immunology of AAV-Mediated Gene Transfer in the Eye

  2013cited by this paper
• Effective delivery of large genes to the retina by dual AAV vectors

  2013cited by this paper
• Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease.

  2013cited by this paper
• AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

  2012cited by this paper
• Intrinsic Protein-Protein Interaction-mediated and Chaperonin-assisted Sequential Assembly of Stable Bardet-Biedl Syndrome Protein Complex, the BBSome*

  2012cited by this paper
• Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

  2012cited by this paper
• Non-syndromic retinal ciliopathies: translating gene discovery into therapy.

  2012cited by this paper
• Autosomal recessive retinitis pigmentosa due to ABCA4 mutations: clinical, pathologic, and molecular characterization.

  2012cited by this paper
• TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice.

  2012cited by this paper
• Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• Bardet–Biedl syndrome

  2012cited by this paper
• Adeno-associated virus biology.

  2011cited by this paper
• Adeno-Associated Virus

  2011cited by this paper
• Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats.

  2011cited by this paper
• Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model

  2011cited by this paper
• Gene Transfer for Neovascular Age-Related Macular Degeneration

  2011cited by this paper
• Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration.

  2011cited by this paper
• Achromatopsie

  2010cited by this paper
• Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration.

  2010cited by this paper
• Deducing the pathogenic contribution of recessive ABCA4 alleles in an outbred population

  2010cited by this paper
• Safety and Efficacy of Subretinal Readministration of a Viral Vector in Large Animals to Treat Congenital Blindness

  2010cited by this paper
• From the laboratory to the clinic: molecular genetic testing in pediatric ophthalmology.

  2010cited by this paper
• Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice

  2010cited by this paper
• Induction of pluripotency by defined factors.

  2010cited by this paper
• Gene therapy rescues cone function in congenital achromatopsia.

  2010cited by this paper
• Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

  2009cited by this paper
• Natural History of Phenotypic Changes in Stargardt Macular Dystrophy

  2009cited by this paper
• ABCA4 disease progression and a proposed strategy for gene therapy.

  2009cited by this paper
• Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions.

  2009cited by this paper
• Which Leber congenital amaurosis patients are eligible for gene therapy trials?

  2009cited by this paper
• Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

  2009cited by this paper
• The functional effect of pathogenic mutations in Rab escort protein 1.

  2009cited by this paper
• Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy.

  2009cited by this paper
• The role of the photoreceptor ABC transporter ABCA4 in lipid transport and Stargardt macular degeneration.

  2009cited by this paper
• Choroideremia: new findings from ocular pathology and review of recent literature.

  2009cited by this paper
• Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

  2008cited by this paper
• Effect of gene therapy on visual function in Leber's congenital amaurosis.

  2008cited by this paper
• Safety and efficacy of gene transfer for Leber's congenital amaurosis.

  2008cited by this paper
• Genetics: the Basics

  2008cited by this paper
• Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

  2008cited by this paper
• Restoration of cone vision in a mouse model of achromatopsia

  2007cited by this paper
• Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B

  2007cited by this paper
• Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2.

  2006cited by this paper
• Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical Trial

  2006cited by this paper
• Rational design and in vitro and in vivo delivery of Dicer substrate siRNA

  2006cited by this paper
• Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.

  2005cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Allele-specific silencing of dominant disease genes

  2003cited by this paper
• Structure of Rab escort protein-1 in complex with Rab geranylgeranyltransferase.

  2003cited by this paper
• Gene therapy restores vision in a canine model of childhood blindness

  2001cited by this paper
• Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder

  2001cited by this paper
• Rab proteins as membrane organizers

  2001cited by this paper
• Usher syndrome: from genetics to pathogenesis.

  2001cited by this paper
• Organization of the Rab‐GDI/CHM Superfamily: The Functional Basis for Choroideremia Disease

  2001cited by this paper
• ABCR expression in foveal cone photoreceptors and its role in stargardt macular dystrophy

  2000cited by this paper
• Suicide Gene Therapy for Treatment of Retinoblastoma in a Murine Model

  1999cited by this paper
• The usher syndromes.

  1999cited by this paper
• Myosin VIIa, the product of the Usher 1B syndrome gene, is concentrated in the connecting cilia of photoreceptor cells.

  1997cited by this paper
• Vision in Leber congenital amaurosis.

  1996cited by this paper
• Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B.

  1995cited by this paper
• The prevalence of blindness and visual impairment among nursing home residents in Baltimore.

  1995cited by this paper
• Aberrant splicing of the CHM gene is a significant cause of choroideremia

  1992cited by this paper
• Twirler: a mutant affecting the inner ear of the house mouse.

  1958cited by this paper

• Kidney failure in Bardet–Biedl syndrome

  2022cites this paper
• Oligomeric Aβ1-42 Induces an AMD-Like Phenotype and Accumulates in Lysosomes to Impair RPE Function

  2021cites this paper
• The uncommon occurrence of two common inherited disorders in a single patient: a mini case series

  2018cites this paper